ClearStar Medical Information Services Monthly Sales Beat USD1 Million

(Alliance News) - ClearStar Inc on Thursday said monthly sales of its Medical Information ...

Alliance News 8 August, 2019 | 10:56AM
Email Form

(Alliance News) - ClearStar Inc on Thursday said monthly sales of its Medical Information Services exceeded USD1 million for the first time in July.

Shares in the background and medical screening technology company jumped 17% to 63.00 pence in morning trade.

Medical Information Services' July sales totalled USD1.1 million, 37% above July 2018 and 47% of the firm's total monthly revenue, having been 45% of revenue the year before.

For the year to July 31, Medical Information Services revenue was 27% higher year-on-year.

ClearStar said Medical Information Services growth is the result of demand for its ClearID background screening product, which was enhanced in the second quarter of the year with the addition of new services to order breath alcohol screening which meets Department of Transportation requirements, including combined drug and alcohol screening.

Chief Executive Robert Vale said: "We are proud to have achieved this milestone of over USD1 million in monthly revenue for Medical Information Services. We are receiving ever-growing demand as customers increasingly recognise the value that our solutions can add to their screening programmes - to benefit both the employer and the employee.

"We are also pleased to introduce our new combined drug and breath alcohol testing service, which is the first step towards our goal of providing complete medical review services."

ClearStar will be publishing its interim result for the six months ended June 30 on September 18.

By Anna Farley;

Copyright 2019 Alliance News Limited. All Rights Reserved.

Email Form

Securities Mentioned in Article

Security Name Price Change (%) Morningstar
ClearStar Inc 39.00 GBX 0.00 -

About Author

Alliance News

Alliance News provides Morningstar with continuously updating coverage of news affecting listed companies.

Audience Confirmation

By clicking 'accept' I acknowledge that this website uses cookies and other technologies to tailor my experience and understand how I and other visitors use our site. See 'Cookie Consent' for more detail.

  • Other Morningstar Websites